Lenti-pp50 TCR (Codon optimized and cysteine modified)-VP(VP-TCR-C425)
The ready-to-use lentiviral particles of Lenti-pp50 TCR (Codon optimized and cysteine modified)-VP is packaged using 3rd generation of lentiviral packaging system, in which the gene of Human TCR will be driven by a CMV promotor. The target gene of TCR packaged in lentiviral particles could be used for high efficency tranduction of T cells and stably integrated expression.
Type of Therapeutics
T cell receptor
CMV pp50 peptide VTEHDTLLY (HLA-A*0101) for stimulation of T-cells. Single peptide (VTEHDTLLY) for stimulation of human CMV pp50-specific CD8+ T-cells. The peptide is synthesised as it is presented by the MHC class I HLA-A*0101 allele. Lyophilized powder. Purity> 80 %, endotoxin free.
65 kDa matrix phosphoprotein; 65 kDa phosphoprotein; Tegument protein pp65; Tegument protein UL83; TCR; T cell receptor; transgenic TCR; antigen-specific T cell receptors; Engineering T-cell receptors; recombinant t cell receptors; specific t cell receptor; modified t cell receptor; retroviral vector; Cytomegalovirus infection
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.